Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625.
Saved in:
| Title: | Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625. |
|---|---|
| Authors: | Boxerman JL; Department of Diagnostic Imaging, Rhode Island Hospital and Alpert Medical School of Brown University, Providence, RI, United States., Snyder BS; Center for Statistical Sciences, Brown University School of Public Health, Providence, RI, United States., Barboriak DP; Department of Radiology, Duke University Medical Center, Durham, NC, United States., Schmainda KM; Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI, United States.; Department of Radiology, Medical College of Wisconsin, Milwaukee, WI, United States. |
| Source: | Frontiers in oncology [Front Oncol] 2023 Jan 26; Vol. 13, pp. 1061502. Date of Electronic Publication: 2023 Jan 26 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
